The potential of an integrated pharmaceutical care model with telepharmacy in adherence and knowledge about pharmacological treatment in patients with mental disorders
A clinical trial
DOI:
https://doi.org/10.1590/Keywords:
Mental disorders, Medication adherence, Knowledge, Controlled clinical trial, TelepharmacyAbstract
The level of understanding about disease and treatment is an important factor to consider in achieving favorable outcomes in patients with mental disorders, and adherence to pharmacological treatment is crucial in this regard. The aim of this study was to assess to what extent patients with MD undergoing an integrated pharmaceutical care model with telepharmacy showed improvements in factors related to treatment adherence and their level of knowledge about pharmacotherapy. A parallel randomized clinical trial was conducted with a two-arm study in two Psychosocial Care Centers located in a state capital in Brazil. Participants in the intervention group received a comprehensive pharmaceutical care model that included attitudinal, technical, and educational interventions, while the control group received standard routine care. Predictive factors for adherence to pharmacological treatment and level of medication knowledge were assessed before and after the intervention. In the intervention group (33), significant improvements were found in the scores of adherence predictors (p<0.001) and the level of knowledge of pharmacotherapy (p<0.001) from baseline to follow-up, compared to the control group (33). The telepharmacy model demonstrated effectiveness in enhancing the scores of adherence predictors for pharmacological treatment and improving the level of knowledge of pharmacotherapy among patients with mental disorders.
Downloads
References
Alcantara CB, Ferreira ACZ, Capistrano FC, Kaled M, Vale CCF, Maftum MA. Conhecimento da pessoa com transtornos mentais sobre o tratamento medicamentoso. Rev Enferm UFSM. 2020; 10(24): 1-19.
Amaral M, Malerbi FEK. Instrumentos de avaliação da adesão ao tratamento utilizados nos artigos do JABA. Rev Bras Ter Comport Cogn. 2019; 21(2): 199-216.
Amer M, Rahman N, Nazir SR, Raza A, Riaz H, Sultana M, et al. Impact of pharmacist’s intervention on disease related knowledge, medication adherence, HRQoL and control of blood pressure among hypertensive patients. Pak J Pharm Sci. 2018; 31(6): 2607-16.
Borba LDO, Maftum MA, Vayego SA, Mantovani MDF, Felix JVC, Kalinke LP. Adesão do portador de transtorno mental à terapêutica medicamentosa no tratamento em saúde mental. Rev Esc Enferm USP. 2018b; 52: e03365.
Borba LO, Capistrano FC, Ferreira ACZ, Kalinke LP, Mantovani MF, Maftum MA. Adaptation and validation of the Measuring of Treatment Adherence for mental health. Rev Bras Enferm. 2018a; 71(5): 2243-50.
Bukhsh A, Khan TM, Sarfraz Nawaz M, Sajjad Ahmed H, Chan KG, Goh BH. Association of diabetes knowledge with glycemic control and self-care practices among Pakistani people with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2019; 12: 1409-17.
Capistrano FC, Maftum MA, Alcântara CB, Ferreira ACZ, Maftum GJ. Dimensões que interferem na adesão à medicação nos transtornos relacionados às substâncias: revisão integrativa. Cogitare Enferm. 2019; 24: e58170.
Conselho Federal de Farmácia. CFF. Resolução CFF nº 727, de 30 de Junho de 2022. Dispõe sobre a regulamentação da telefarmácia. Diário Oficial da União, Brasília, 20 jul. 2022. Seção 1, p. 179.
Conselho Federal de Medicina. CFM. Resolução CFM nº 2.314, de 20 de abril de 2022. Define e regulamenta a telemedicina, como forma de serviços médicos mediados por tecnologias de comunicação. Diário Oficial da União, Brasília, 05 mai. 2022. Seção 1, p. 227.
Cordioli AV, Kieling C, Da Silva CTB, Passos IC, Barcellos MT. Manual Diagnóstico e Estatístico de Transtornos Mentais: DSM-5. 5ª ed. Porto Alegre: Artmed Editora; 2014.
da Silva CRC, de Souza GHP, Santiago NR, de Carvalho NCBG, Modesto ACF, Provin MP. Validação de instrumento para mensurar a adesão ao tratamento farmacológico em pacientes psiquiátricos. RECIMA21. 2023; 4(10): e4104071.
Ferreira TXAM, Prudente LR, Dewulf NDLS, Provin MP, Cardoso TC, Silveira EAD, et al. Impact of a drug dispensing model at a Community Pharmacy in Goiânia, Goiás, Brazil. Braz J Pharm Sci. 2018; 54(4): e00143.
Figlie NB, Guimarães LP. The Motivational interview: conversations about changes. Bol. Acad Paul Psicol. 2014; 34(87): 472-489.
Fitzgerald AA, Powers JD, Ho PM, Maddox TM, Peterson PN, Allen LA, et al. Impact of medication nonadherence on hospitalizations and mortality in heart failure. J Card Fail. 2011; 17(8): 664-69.
Fröhlich SE, Dal Pizzol TS, Mengue SS. Instrument to evaluate the level of knowledge about prescription in primary care. Rev Saude Publica. 2010; 44(6): 1046-54.
Gast A, Mathes T. Medication adherence influencing factors-an (updated) overview of systematic reviews. Syst reviews. 2019; 8(1): 1-17.
Hartung D, Low A, Jindai K, Mansoor D, Judge M, Mendelson A, et al. Interventions to Improve Pharmacological Adherence Among Adults With Psychotic Spectrum Disorders and Bipolar Disorder: A Systematic Review. Psychosomatics. 2017; 58(2): 101-12.
Hefti E, Wei B, Engelen K. Access to Telepharmacy Services May Reduce Hospital Admissions in Outpatient Populations During the COVID-19 Pandemic. Telemed J E Health. 2022; 28(9): 1324-31
Hernández AB, Valdivieso MG, Arasa J, Pintor EL. Study Review of the advantages and disadvantages of Dose Administration Aids (DDA) and evaluation of their adequacy to the patient’s profile and type of pharmacy. Farmajournal. 2020; 5(1): 47-54.
Instituto Brasileiro de Geografia e Estatística. IBGE. Diretoria de pesquisas, coordenação de população e indicadores sociais. Estimativas da população residente em Goiânia. 2021. [citado em 2022 fev. 25]. Disponível em: Disponível em: https://cidades.ibge.gov.br/brasil/go/goiania/panorama
» https://cidades.ibge.gov.br/brasil/go/goiania/panorama
Jungerman FS, Laranjeira R. Entrevista motivacional: bases teóricas e práticas. J Bras Psiquiatr. 1999; 48(5): 197-207.
Kohn R, Ali AA, Puac-Polanco V, Figueroa C, López-Soto V, Morgan K, et al. Mental health in the Americas: an overview of the treatment gap. Rev Panam Salud Publica. 2018; 42: e165.
Melchiors AC, Correr CJ, Fernández-Llimos F. Translation and validation into portuguese language of the medication regimen complexity index. Arq Bras Cardiol. 2007; 89(4): 210-18.
Miller W, Rollnick S. Entrevista motivacional: preparando as pessoas para mudança de comportamentos aditivos. Porto Alegre: Artes Médicas, 2001.
Milosavljevic A, Aspden T, Harrison J. Community pharmacist-led interventions and their impact on patients’ medication adherence and other health outcomes: a systematic review. Int J Pharm Pract. 2018; 26(5): 387-97.
Moraes RSM, Silva DAS, Oliveira WF, Peres MA. Social inequalities in the prevalence of common mental disorders in adults: a population-based study in southern Brazil. Rev Bras Epidemiol. 2017; 20(1): 43-56.
Ng R, El-Den S, Stewart V, Collins JC, Roennfeldt H, McMillan SS, et al. Pharmacistled interventions for people living with severe and persistent mental illness: A systematic review. Aust N Z J Psychiatry. 2021; 24.
Poonprapai P, Lerkiatbundit S, Saengcharoen W. Family support-based intervention using a mobile application provided by pharmacists for older adults with diabetes to improve glycaemic control: a randomised controlled trial. Int J Clin Pharm. 2022; 44: 680-88.
Quadros LCM, Quevedo LA, Gonçalves HD, Horta BL, Motta JVDS, Gigante DP. Common mental disorders and contemporary factors: 1982 birth cohort. Rev Bras Enferm. 2020; 73(1): e20180162.
Quemel GKC, Da Silva EP, Conceição WR, Gomes MF, Rivera JGB, Quemel GKC. Revisão integrativa da literatura sobre o aumento no consumo de psicotrópicos em transtornos mentais como a depressão. Braz Ap Sci Rev. 2021; 5(3): 1384-1403.
Readdean KC, Heuer AJ, Scott Parrott J. Effect of pharmacist intervention on improving antidepressant medication adherence and depression symptomology: A systematic review and meta-analysis. Res Social Adm Pharm. 2018; 14(4): 321-31.
Rocha GC, Pires MCPC, Teixeira HS. Pictogramas: estratégias para auxílio aos idosos no uso correto dos medicamentos. Braz J Dev. 2021; 7(12): 12074-78.
Sharma N, Srivastav AK, Samuel AJ. Randomized clinical trial: gold standard of experimental designs-importance, advantages, disadvantages and prejudices. Rev Pesqui Fisioter. 2020; 10(3): 512-19.
Silva SN, Lima MG, Ruas CM. Pharmaceutical interventions in mental health: a review of the literature to support evidence-informed policymaking. Res Social Adm Pharm. 2018; 14(10): 891-00.
Spencer EA, Mahtani K. Hawthorne effect. Catalog of bias. 2017.
Torres-Robles A, Wiecek E, Tonin FS, Benrimoj SI, Fernandez-Llimos F, Garcia-Cardenas V. Comparison of interventions to improve long-term medication adherence across different clinical conditions: a systematic review with network meta-analysis. Front Pharmacol. 2018; 9: 1454.
Vicente A, Mónico B, Lourenço M, Lourenço O. Dose Administration Aid Service in Community Pharmacies: Characterization and Impact Assessment. Pharmacy. 2021; 9(4): 190.
World Health Organization. WHO. Mental health: new conception, new hope. Geneva: World Health Organization; 2001. 169p. [citado 2021 nov. 06]. Disponível em: Disponível em: https://www.who.int/whr/2001/en/whr01_po.pdf
» https://www.who.int/whr/2001/en/whr01_po.pdf
Yeni K, Tulek Z, Simsek OF, Bebek N. Relationships between knowledge, attitudes, stigma, anxiety and depression, and quality of life in epilepsy: A structural equation modeling. Epilepsy Behav. 2018; 85: 212-17.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
